Yuwen Xue

534 total citations
16 papers, 344 citations indexed

About

Yuwen Xue is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuwen Xue has authored 16 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuwen Xue's work include Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (3 papers) and Immune Cell Function and Interaction (2 papers). Yuwen Xue is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (3 papers) and Immune Cell Function and Interaction (2 papers). Yuwen Xue collaborates with scholars based in China, United States and Australia. Yuwen Xue's co-authors include Yunshan Wang, Min Zhang, Li Mao, Yanfei Jia, Yingjie Li, Yi Zhang, Nan Lü, Hening Ren, Ronghui Xia and Ruxian Lin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Yuwen Xue

16 papers receiving 338 citations

Peers

Yuwen Xue
Comparison fields: 5 of 73
  • Molecular Biology 207
  • Cancer Research 75
  • Oncology 74
  • Immunology 52
  • Biomedical Engineering 35
Replace Lei Lou with:
Lei Lou China
Farhad Jadidi-Niaragh Iran
Yi-Fan Zhou China
Fahimeh Fattahi Iran
Monica Montone Italy
Alessandro Magrì Italy
Lingzhang Meng China
Ania Wronski United States
Zhaoqian Liu China
Kailiang Qiao China
Lei Lou China View profile →
Citations per field, relative to Yuwen Xue
Yuwen Xue · 1×
Citations per year, relative to Yuwen Xue
Yuwen Xue · 1×

Countries citing papers authored by Yuwen Xue

Since Specialization
Citations

This map shows the geographic impact of Yuwen Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuwen Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuwen Xue more than expected).

Fields of papers citing papers by Yuwen Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuwen Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuwen Xue. The network helps show where Yuwen Xue may publish in the future.

Co-authorship network of co-authors of Yuwen Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Yuwen Xue. A scholar is included among the top collaborators of Yuwen Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuwen Xue. Yuwen Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
# Work Indexed citations
1 11
2 1
3 15
4 3
5 29
6 12
7 28
8 16
9 12
10 1
11 28
12 68
13 11
14 82
15 26
16
Expressions of Survivin, microvessel density in non-small cell lung cancer and their correlation with prognosis
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026